Drug intelligence / Profile preview

Jaungo

Development stage: Phase 2
Lead developer: Kyung Hee University Hospital
Administration: Topical

Overview

Jaungo is a traditional herbal ointment used in East Asian medicine (Korea, Japan, and China) for the treatment of various skin conditions, including atopic dermatitis, burns, wounds, and eczema. The formulation typically consists of extracts from *Lithospermum erythrorhizon* (Gromwell root) and *Angelica gigas* (Korean Angelica) prepared in a base of sesame oil and beeswax. The primary active components, such as shikonin derivatives from *Lithospermum erythrorhizon*, are recognized for their anti-inflammatory, antimicrobial, and wound-healing properties. Kyung Hee University Hospital has evaluated Jaungo in clinical trials as a topical therapeutic for mild to moderate atopic dermatitis to establish its efficacy and safety profile.

Brand names: JaungoShiunko (in Chinese and Japanese)
Other names: ShiunkoZi Yun Gao

Beyond the preview

Go deeper on Jaungo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jaungo.

Explore the full profile